Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 28, 2015 4:39 AM ET

Biotechnology

Company Overview of Xigen SA

Executive Profile

Peter M. A. Calverley M.D.

Member of Scientific Advisory Board, Xigen SA
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Peter M. A. Calverley,,MD is Professor of Respiratory Medicine of University of Liverpool. Mr. Calverley is Honorary Consultant Physician, University Hospital Aintree. He serves at Department of Cellular Biology and Morphology, University of Lausanne, Switzerland. He serves as Member of Scientific Advisory Board of Xigen SA. He is an expert on neuronal death, and more than 80 of his papers in international journals focus on this subject. His research has been recognized ...

Corporate Headquarters

17, rue des Terreaux
Lausanne, Vaud 1003

Switzerland

Phone: 41 21 321 10 80
Fax: 41 21 321 10 81

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Xigen SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.